 Home > Medical News > Latest Medical News > The State Food and Drug Administration approves the marketing of Donafinil tosylate tablets

The State Food and Drug Administration approves the marketing of Donafinil tosylate tablets

 Last Update: 2021-06-22
 Source: Internet
 Author: User

Tags

drug interaction database

hair growth drug

what class drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 9, the official website of the State Food and Drug Administration announced that the State Food and Drug Administration recently passed the priority review and approval procedure to approve the Class 1 innovative drug Donafenib Tosylate (trade name:) declared by Suzhou Zejing Biopharmaceutical Co.
, Ltd.
Zepson) went public
.

The drug is an innovative drug independently researched and developed by China with independent intellectual property rights.

Donafenib (Donafenib) is a multi-kinase inhibitor class of small molecule anti-tumor drugs
.

The listing of this variety provides a new treatment option for patients with hepatocellular carcinoma

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.